MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
38.82
-2.09
-5.11%
After Hours: 38.79 -0.03 -0.08% 16:29 03/28 EDT
OPEN
40.87
PREV CLOSE
40.91
HIGH
40.95
LOW
38.59
VOLUME
613.30K
TURNOVER
0
52 WEEK HIGH
40.95
52 WEEK LOW
20.83
MARKET CAP
1.24B
P/E (TTM)
33.69
1D
5D
1M
3M
1Y
5Y
Collegium Pharmaceutical (NASDAQ:COLL) shareholder returns have been stellar, earning 154% in 5 years
Collegium Pharmaceutical, Inc. Stock is up 154% over the last five years. The stock has added US$63m to its market cap in the last week alone. The company moved from a loss to profitability in the same period. Collegium Pharmaceutical shareholders have received a total shareholder return of 65% The company's share price is up 67% in the past three years.
Simply Wall St · 2d ago
Weekly Report: what happened at COLL last week (0318-0322)?
Weekly Report · 4d ago
Humana (HUM), DUOS Unveil Program to Improve Veterans' Health
NASDAQ · 03/21 17:39
IXJ: Healthcare Sector Dashboard For March
IShares Global Healthcare ETF is overvalued by about 13% relative to 11-year averages. Healthcare equipment has the worst value and quality scores. The healthcare sector is the most overvalued in the U.S. In March 2024. This monthly article series shows a dashboard with aggregate industry metrics in healthcare.
Seeking Alpha · 03/18 18:07
Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron
NASDAQ · 03/18 11:46
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
NASDAQ · 03/18 10:46
Weekly Report: what happened at COLL last week (0311-0315)?
Weekly Report · 03/18 09:26
Time to Get These 5 Top Relative Price Strength Stocks
NASDAQ · 03/15 10:39
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed with abuse deterrent properties and uses a technology platform, DETERx. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic. Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Symproic is used for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.